Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG

• Status: Completed
• Trial end date: 2018-01-30
• Target enrollment: 0
• Participant gender: All

Summary

Proper bowel cleansing before colonoscopy is an important factor to increase the detection rate of lesions. Low volume polyethylene glycol (PEG) plus ascorbic (PEG-Asc) has reduced the dosage of previous bowel preparation agent, but it still presents discomfort to patients. The aim of this study was to confirm the efficacy and convenience of volume reduction of PEG-Asc by adding bisacodyl suppository at the same day by compared with conventional 2L PEG-Asc.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Samsung Medical Center
• Treatments: Bisacodyl

Criteria

Inclusion Criteria:

• outpatients who were scheduled for colonoscopy between August 2017 and January 2018

Exclusion Criteria:

• History of gastrointestinal tract surgery

• History of inflammatory bowel disease

• History of severe active colitis

• History of chronic kidney disease

• pregnant woman.